account_num,net_change,tag,tag_depth,cik
2590,-3046900000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,875045_BIOGEN INC.
162,336200000.0,CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization,6,875045_BIOGEN INC.
3809,-164900000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,875045_BIOGEN INC.
3817,2977100000.0,TreasuryStockValue,2,875045_BIOGEN INC.
3494,-944200000.0,OtherLiabilitiesNoncurrent,2,875045_BIOGEN INC.
3383,-334700000.0,DeferredIncomeTaxLiabilitiesNet,2,875045_BIOGEN INC.
2552,-259900000.0,AccruedLiabilitiesCurrent,2,875045_BIOGEN INC.
1901,1226400000.0,DeferredIncomeTaxAssetsNet,2,875045_BIOGEN INC.
1848,705700000.0,LongTermInvestmentsAndReceivablesNet,3,875045_BIOGEN INC.
1626,705700000.0,LongTermInvestments,1,875045_BIOGEN INC.
281,1473500000.0,ShortTermInvestments,1,875045_BIOGEN INC.
2903,-3046900000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,875045_BIOGEN INC.
171,2278300000.0,CostOfGoodsAndServicesSold,2,875045_BIOGEN INC.
144,2278300000.0,CostOfRevenue,1,875045_BIOGEN INC.
581,2481800000.0,OperatingCostsAndExpenses,2,875045_BIOGEN INC.
1506,705700000.0,DebtSecuritiesNoncurrent,2,875045_BIOGEN INC.
1356,705700000.0,AvailableForSaleSecuritiesDebtSecuritiesNoncurrent,3,875045_BIOGEN INC.
1209,-1505400000.0,EquityMethodInvestmentRealizedGainLossOnDisposal,2,875045_BIOGEN INC.
375,2231100000.0,ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost,2,875045_BIOGEN INC.
914,263500000.0,AllocatedShareBasedCompensationExpense,2,875045_BIOGEN INC.
825,119600000.0,GoodwillAndIntangibleAssetImpairment,2,875045_BIOGEN INC.
795,336200000.0,ProductionRelatedImpairmentsOrCharges,1,875045_BIOGEN INC.
759,336200000.0,InventoryWriteDown,1,875045_BIOGEN INC.
174,1473500000.0,AvailableForSaleSecuritiesDebtSecuritiesCurrent,3,875045_BIOGEN INC.
184,1473500000.0,DebtSecuritiesCurrent,2,875045_BIOGEN INC.
802,119600000.0,AssetImpairmentCharges,1,875045_BIOGEN INC.
1781,-1505400000.0,NonoperatingGainsLosses,1,875045_BIOGEN INC.
1133,250700000.0,RestructuringSettlementAndImpairmentProvisions,3,875045_BIOGEN INC.
830,119600000.0,ImpairmentOfIntangibleAssetsExcludingGoodwill,1,875045_BIOGEN INC.
1455,-1505400000.0,GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee,1,875045_BIOGEN INC.
1215,131100000.0,RestructuringCharges,1,875045_BIOGEN INC.
2431,85300000.0,NetIncomeLossAttributableToNoncontrollingInterest,1,875045_BIOGEN INC.
3853,-9500000.0,MinorityInterest,1,875045_BIOGEN INC.
2841,-259900000.0,TaxesPayableCurrent,2,875045_BIOGEN INC.
757,1417600000.0,OtherAssetsCurrent,2,875045_BIOGEN INC.
1478,-2600000.0,IncomeLossFromEquityMethodInvestments,1,875045_BIOGEN INC.
491,2231100000.0,ResearchAndDevelopmentExpense,2,875045_BIOGEN INC.
232,-12451700000.0,GrossProfit,1,875045_BIOGEN INC.
173,-10173400000.0,Revenues,1,875045_BIOGEN INC.
3917,-24554100000.0,LiabilitiesAndStockholdersEquity,2,875045_BIOGEN INC.
3260,-13388400000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,875045_BIOGEN INC.
3316,-13397900000.0,StockholdersEquity,1,875045_BIOGEN INC.
3834,-16466500000.0,RetainedEarningsAccumulatedDeficit,1,875045_BIOGEN INC.
597,263500000.0,GeneralAndAdministrativeExpense,2,875045_BIOGEN INC.
3750,-73300000.0,AdditionalPaidInCapital,1,875045_BIOGEN INC.
3465,-11165700000.0,Liabilities,1,875045_BIOGEN INC.
3645,-1611900000.0,LiabilitiesNoncurrent,2,875045_BIOGEN INC.
3796,-1611900000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,875045_BIOGEN INC.
3379,-333000000.0,OperatingLeaseLiabilityNoncurrent,3,875045_BIOGEN INC.
3154,-3272800000.0,LiabilitiesCurrent,2,875045_BIOGEN INC.
3017,-2521400000.0,OtherLiabilitiesCurrent,2,875045_BIOGEN INC.
3661,-100000.0,CommonStockValue,3,875045_BIOGEN INC.
2347,-751400000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,875045_BIOGEN INC.
601,2403600000.0,SellingGeneralAndAdministrativeExpense,3,875045_BIOGEN INC.
1002,-503700000.0,GainLossOnDispositionOfAssets1,1,875045_BIOGEN INC.
1077,-2961600000.0,ProfitLoss,2,875045_BIOGEN INC.
1820,-4227200000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,875045_BIOGEN INC.
961,-503700000.0,GainLossOnSaleOfPropertyPlantEquipment,1,875045_BIOGEN INC.
2399,632800000.0,IncomeTaxExpenseBenefit,1,875045_BIOGEN INC.
2257,-3594400000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,875045_BIOGEN INC.
2149,-3591800000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,875045_BIOGEN INC.
2130,-108200000.0,NonoperatingIncomeExpense,1,875045_BIOGEN INC.
1205,-1505400000.0,InvestmentIncomeNonoperating,2,875045_BIOGEN INC.
1264,-17840800000.0,OperatingIncomeLoss,1,875045_BIOGEN INC.
1112,5389100000.0,OperatingExpenses,1,875045_BIOGEN INC.
819,168600000.0,DeferredIncomeTaxExpenseBenefit,1,875045_BIOGEN INC.
2398,-491500000.0,AccountsPayableCurrent,2,875045_BIOGEN INC.
2091,14762900000.0,AssetsNoncurrent,2,875045_BIOGEN INC.
2089,24554100000.0,Assets,1,875045_BIOGEN INC.
2041,1529200000.0,OtherAssetsNoncurrent,2,875045_BIOGEN INC.
1827,7599100000.0,IntangibleAssetsNetIncludingGoodwill,2,875045_BIOGEN INC.
1732,1850100000.0,IntangibleAssetsNetExcludingGoodwill,2,875045_BIOGEN INC.
1711,5749000000.0,Goodwill,1,875045_BIOGEN INC.
1368,3298600000.0,PropertyPlantAndEquipmentNet,4,875045_BIOGEN INC.
1634,403900000.0,OperatingLeaseRightOfUseAsset,2,875045_BIOGEN INC.
868,9791200000.0,AssetsCurrent,2,875045_BIOGEN INC.
455,1344400000.0,InventoryNet,2,875045_BIOGEN INC.
320,1705000000.0,ReceivablesNetCurrent,3,875045_BIOGEN INC.
207,1705000000.0,AccountsNotesAndLoansReceivableNetCurrent,4,875045_BIOGEN INC.
229,1705000000.0,AccountsReceivableNetCurrent,3,875045_BIOGEN INC.
577,1473500000.0,CashCashEquivalentsAndShortTermInvestments,4,875045_BIOGEN INC.
260,1344400000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,875045_BIOGEN INC.
1912,-3046900000.0,NetIncomeLoss,1,875045_BIOGEN INC.
